642 related articles for article (PubMed ID: 17991318)
1. [Correlation of E-cadherin hypermethylation to tumorigenesis and development of gastric cancer].
Liu WT; Jiao HL; Yang YL; Wang D; Zhang WM
Ai Zheng; 2007 Nov; 26(11):1199-203. PubMed ID: 17991318
[TBL] [Abstract][Full Text] [Related]
2. [CpG island methylation of E-cadherin gene promoter in gastric carcinoma].
Zhou YN; Xu CP; Han B; Ji R
Ai Zheng; 2005 Oct; 24(10):1220-4. PubMed ID: 16219136
[TBL] [Abstract][Full Text] [Related]
3. E-cadherin expression in early gastric carcinoma and correlation with lymph node metastasis.
Yi Kim D; Kyoon Joo J; Kyu Park Y; Yeob Ryu S; Soo Kim H; Kyun Noh B; Hwa Lee K; Hyuk Lee J
J Surg Oncol; 2007 Oct; 96(5):429-35. PubMed ID: 17786966
[TBL] [Abstract][Full Text] [Related]
4. Promoter hypermethylation of multiple genes in early gastric adenocarcinoma and precancerous lesions.
Zou XP; Zhang B; Zhang XQ; Chen M; Cao J; Liu WJ
Hum Pathol; 2009 Nov; 40(11):1534-42. PubMed ID: 19695681
[TBL] [Abstract][Full Text] [Related]
5. [Expression and clinical significance of Mucin and E-cadherin in colorectal tumors].
Yu XW; Rong W; Xu FL; Xu GY; Sun YR; Feng MY
Ai Zheng; 2007 Nov; 26(11):1204-10. PubMed ID: 17991319
[TBL] [Abstract][Full Text] [Related]
6. Promoter-hypermethylation associated defective expression of E-cadherin in primary non-small cell lung cancer.
Wang G; Hu X; Lu C; Su C; Luo S; Luo ZW
Lung Cancer; 2008 Nov; 62(2):162-72. PubMed ID: 18468719
[TBL] [Abstract][Full Text] [Related]
7. Correlation of a single nucleotide polymorphism in the E-cadherin gene promoter with tumorigenesis and progression of gastric carcinoma in Japan.
Kuraoka K; Oue N; Yokozaki H; Kitadai Y; Ito R; Nakayama H; Yasui W
Int J Oncol; 2003 Aug; 23(2):421-7. PubMed ID: 12851691
[TBL] [Abstract][Full Text] [Related]
8. Wnt pathway is involved in advanced gastric carcinoma.
Zhang H; Xue Y
Hepatogastroenterology; 2008; 55(84):1126-30. PubMed ID: 18705344
[TBL] [Abstract][Full Text] [Related]
9. [Expression and significance of cell cycle regulators in gastric carcinoma].
Wu JF; Shao JC; Wang DB; Qin R; Zhang H
Ai Zheng; 2005 Feb; 24(2):175-9. PubMed ID: 15694028
[TBL] [Abstract][Full Text] [Related]
10. Expression levels of cyclin G2, but not cyclin E, correlate with gastric cancer progression.
Choi MG; Noh JH; An JY; Hong SK; Park SB; Baik YH; Kim KM; Sohn TS; Kim S
J Surg Res; 2009 Dec; 157(2):168-74. PubMed ID: 19559447
[TBL] [Abstract][Full Text] [Related]
11. [Studies of promoter methylation status and protein expression of E-cadherin gene in associated progression stages of gastric cancer].
Zheng ZH; Sun XJ; Ma MC; Hao DM; Liu YH; Sun KL
Yi Chuan Xue Bao; 2003 Feb; 30(2):103-8. PubMed ID: 12776596
[TBL] [Abstract][Full Text] [Related]
12. Pathology and prognosis of gastric carcinoma: well versus poorly differentiated type.
Adachi Y; Yasuda K; Inomata M; Sato K; Shiraishi N; Kitano S
Cancer; 2000 Oct; 89(7):1418-24. PubMed ID: 11013353
[TBL] [Abstract][Full Text] [Related]
13. Methylation of protocadherin 10, a novel tumor suppressor, is associated with poor prognosis in patients with gastric cancer.
Yu J; Cheng YY; Tao Q; Cheung KF; Lam CN; Geng H; Tian LW; Wong YP; Tong JH; Ying JM; Jin H; To KF; Chan FK; Sung JJ
Gastroenterology; 2009 Feb; 136(2):640-51.e1. PubMed ID: 19084528
[TBL] [Abstract][Full Text] [Related]
14. Positive association of up-regulated Cripto-1 and down-regulated E-cadherin with tumour progression and poor prognosis in gastric cancer.
Zhong XY; Zhang LH; Jia SQ; Shi T; Niu ZJ; Du H; Zhang GG; Hu Y; Lu AP; Li JY; Ji JF
Histopathology; 2008 Apr; 52(5):560-8. PubMed ID: 18312357
[TBL] [Abstract][Full Text] [Related]
15. Loss of E-cadherin expression resulting from promoter hypermethylation in oral tongue carcinoma and its prognostic significance.
Chang HW; Chow V; Lam KY; Wei WI; Yuen A
Cancer; 2002 Jan; 94(2):386-92. PubMed ID: 11900224
[TBL] [Abstract][Full Text] [Related]
16. Hypermethylation in promoter region of E-cadherin gene is associated with tumor dedifferention and myometrial invasion in endometrial carcinoma.
Saito T; Nishimura M; Yamasaki H; Kudo R
Cancer; 2003 Feb; 97(4):1002-9. PubMed ID: 12569599
[TBL] [Abstract][Full Text] [Related]
17. CpG methylation of transcription factor 4 in gastric carcinoma.
Joo JK; Kim SH; Kim HG; Kim DY; Ryu SY; Lee KH; Lee JH
Ann Surg Oncol; 2010 Dec; 17(12):3344-53. PubMed ID: 20585880
[TBL] [Abstract][Full Text] [Related]
18. [Down-regulation of caveolin-1 in gastric carcinoma and its clinical biological significance].
Gao X; Sun Y; Huang L; Chen XY; Zhang KL; Kong QY; Liu J; Li H
Ai Zheng; 2005 Mar; 24(3):311-6. PubMed ID: 15757532
[TBL] [Abstract][Full Text] [Related]
19. CpG hypermethylation of promoter region and inactivation of E-cadherin gene in human bladder cancer.
Ribeiro-Filho LA; Franks J; Sasaki M; Shiina H; Li LC; Nojima D; Arap S; Carroll P; Enokida H; Nakagawa M; Yonezawa S; Dahiya R
Mol Carcinog; 2002 Aug; 34(4):187-98. PubMed ID: 12203370
[TBL] [Abstract][Full Text] [Related]
20. Increased DNA methyltransferase 1 (DNMT1) protein expression correlates significantly with poorer tumor differentiation and frequent DNA hypermethylation of multiple CpG islands in gastric cancers.
Etoh T; Kanai Y; Ushijima S; Nakagawa T; Nakanishi Y; Sasako M; Kitano S; Hirohashi S
Am J Pathol; 2004 Feb; 164(2):689-99. PubMed ID: 14742272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
